manager
July 5, 2020
COVID-19 has rekindled debate about pharmaceutical supply chains and prompted renewed calls for drug companies to source more active pharmaceutical ingredients (APIs) from the US and Europe. China is a major API, raw materials and intermediates supplier, and according to US Food and Drug Administration (FDA), 13% of the plants supplying APIs for US drugs are in China [1]. Likewise, many European pharmaceutical companies rely on China for APIs. Also, […]
June 26, 2020
It would be disingenuous to claim 2019 was a revolutionary year for pharma as it continues its journey towards a patient-centric model. The twin objectives of unlocking innovative potential to bring new products to market and bettering patient lives in a rapidly evolving global landscape remain unchanged. The journey is well underway, and companies are in the process of mapping out how they reach this futuristic destination. Trends to look […]
